Breaking News on MFN ‘Targets’ … and a Review of the Right’s Reaction to the Policy

If we’re being honest, the force that is going to end the ever-escalating trend of PBM-fueled rebates and the accompanying shell game is probably not going to be legislative action,

I’m paying the price for yesterday’s decision to go all-in on the Minnesota 340B report. There’s a lot to get through. Pitter patter.  Tomorrow’s Curve will be a game-time decision,

There may be no drug-pricing myth more pernicious than the idea that the NIH does all the drug research, and companies just sweep in at the eleventh hour, ram medicines